search
Back to results

Sleep and Tracking Effects in Pregnancy Study (STEP)

Primary Purpose

Pregnancy Complications, Pregnancy Related, Weight Gain

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Activity Intervention
Sponsored by
University of North Carolina, Chapel Hill
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Pregnancy Complications

Eligibility Criteria

18 Years - 51 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • At high risk for adverse pregnancy outcomes, due to either body mass index ≥ 30 kg/m^2, or a prior history of preeclampsia, intrauterine growth restriction or preterm birth prior to 37 weeks' gestation in a previous pregnancy and a perceived stress score of >/= 14 (10-question scale)
  • Gestational age of 8.0 to 19.9 weeks' gestation using American College of Obstetricians and Gynecologists dating criteria (combination of ultrasound and menstrual dating, as available)
  • Current singleton viable intrauterine pregnancy. Spontaneous reduction of twin to singleton gestation is allowable provided it occurred prior to 14 weeks' gestation.
  • No structural abnormalities or aneuploidy
  • Ability to communicate in and provide consent in English
  • Maternal age 18 to 51 years of age
  • Owns smartphone compatible with wrist-based activity tracker (over 200 devices supported)

Exclusion Criteria:

  • Women pregnant with multifetal gestations
  • Women who have a medical condition where a modest increase in low-impact activity is contraindicated (at the discretion of the woman's treating physician)
  • Planned delivery prior to 36 weeks' of gestation
  • Unwilling to wear wrist-based activity tracker for at least 6 out of 7 days per week

Sites / Locations

  • University of North Carolina

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Usual care

Activity Intervention

Arm Description

Women randomized to this group will receive no guidance regarding exercise / activity / sleep during pregnancy.

Women randomized to this group will receive detailed information and reminders about physical activity and sleep in pregnancy. .

Outcomes

Primary Outcome Measures

Reduction in Perceived Maternal Stress
Perceived stress score will be calculated using a validated 10-question stress scale; score = 14 indicates moderate stress
Proportion of women with adverse perinatal outcomes
The investigators will define adverse pregnancy outcomes as a composite of preterm birth <37 weeks, intrauterine growth restriction, preeclampsia, and placental abruption; outcomes will be compared between randomization groups.

Secondary Outcome Measures

Number of activity goals met by personalized activity level group
Proportion of weekly activity goals that were successfully met by women randomized to personalized activity group
Mean Daily steps
Mean number of daily steps; amount will be compared between randomization groups.
Median Daily steps
median number of daily steps; amount will be compared between randomization groups.
Mean 'Moderate' or greater physical activity
Mean number of weekly minutes of 'moderate' or 'intense' physical activity as registered by the wrist-based activity monitor; amount will be compared between randomization groups.
Median 'Moderate' or greater physical activity
median number of weekly minutes of 'moderate' or 'intense' physical activity as registered by the wrist-based activity monitor; amount will be compared between randomization groups.
Mean Nightly sleep minutes
Mean number of sleep minutes per night; amount will be compared between randomization groups.
Median Nightly sleep minutes
median number of sleep minutes per night; amount will be compared between randomization groups.
Median resting heart rate parameters
The change in the median resting heart rate level and nadir of the resting heart rate (in beats per minute), between enrollment and delivery ; amount will be compared between randomization groups.
Mean Resting heart rate parameters
The change in the mean resting heart rate level and nadir of the resting heart rate (in beats per minute), between enrollment and delivery ; amount will be compared between randomization groups.
Median Body composition change during study - total body water
The change in median total body water measurements between enrollment and re-assessment at 8 and 16 weeks (as applicable, if still pregnant) after enrollment will be compared between randomization groups.
Mean Body composition change during study - total body water
The change in mean total body water measurements between enrollment and re-assessment at 8 and 16 weeks (as applicable, if still pregnant) after enrollment will be compared between randomization groups.
Median Body composition change during study - percent body fat
The change in median percent body fat measurements between enrollment and re-assessment at 8 and 16 weeks (as applicable, if still pregnant) after enrollment will be compared between randomization groups.
Mean Body composition change during study - percent body fat
The change in mean percent body fat measurements between enrollment and re-assessment at 8 and 16 weeks (as applicable, if still pregnant) after enrollment will be compared between randomization groups.
Gestational weight gain
The amount of weight gained by each participant during pregnancy, in pounds. outcomes will be compared between randomization groups.
Gestational weight gain, per week after study enrollment
The amount of weight gained per week by each participant, in pounds, between study enrollment and delivery. outcomes will be compared between randomization groups.
Proportion of women with gestational diabetes mellitus
The diagnosis of gestational diabetes mellitus during pregnancy, using standard criteria as set forth by American College of Obstetricians and Gynecologists. outcomes will be compared between randomization groups.
Proportion of women with hypertensive complications of pregnancy
The diagnosis of gestational hypertension, preeclampsia, or eclampsia, using standard American College of Obstetricians and Gynecologists diagnostic criteria. outcomes will be compared between randomization groups.

Full Information

First Posted
November 20, 2019
Last Updated
September 12, 2022
Sponsor
University of North Carolina, Chapel Hill
search

1. Study Identification

Unique Protocol Identification Number
NCT04173559
Brief Title
Sleep and Tracking Effects in Pregnancy Study
Acronym
STEP
Official Title
Improving Perinatal Outcomes Through Activity and Sleep Tracking
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
May 2023 (Anticipated)
Primary Completion Date
May 14, 2025 (Anticipated)
Study Completion Date
May 14, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of North Carolina, Chapel Hill

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Purpose: The investigators hypothesize that a simple, personalized, smartphone-based activity intervention using a wrist-based activity tracker will help high risk pregnant women reduce their stress during pregnancy. Participants: Pregnant women enrolled in prenatal care at the University of North Carolina who have a documented moderate or high level of perceived stress ( ≥ 14) and are at high risk for adverse pregnancy outcomes due to body mass index of ≥ 30 kg/m2 or history of gestational hypertension, preeclampsia, intrauterine growth restriction, or preterm birth <37 weeks' in a prior pregnancy. Procedures: Women meeting inclusion criteria will be recruited through the University of North Carolina prenatal care clinics. They will be contacted for possible participation at regularly scheduled prenatal visits and/or ultrasound. They may also be contacted for possible participation by remote methods (e.g., Telehealth). Women who are enrolled will complete validated dietary, stress, sleep, and body image questionnaires. Enrolled women will then be randomized to receive standard obstetrical care or enhanced counseling. All participants will receive a wrist-based activity tracker. Maternal blood sample for biochemical markers of stress and gene expression will be obtained at the initial visit; a followup blood sample will be obtained later in pregnancy, and a small portion of the placenta saved at delivery. Maternal and neonatal outcomes will be compared between groups.
Detailed Description
During pregnancy, women regularly interact with healthcare professionals, an often untapped resource and opportune time to minimize stress and optimize weight gain, nutrition, and activity, positively impacting outcomes and lifelong health. The overarching hypothesis of this study is that a simple, personalized, smartphone-based activity intervention using a wrist-based activity tracker will help high risk pregnant women increase their activity level during pregnancy, reduce stress, and optimize gestational weight gain and biometric parameters. Importantly, the investigators propose that women can be engaged in care via a simple, personalized text-message based intervention. Women will be enrolled early in pregnancy and followed prospectively. All women will receive a wrist-based activity tracker. Some women (those randomized to receive individualized counseling) will receive weekly text messages based on their activity and sleep in the prior week. Other women will not receive any specific instructions regarding activity level. The investigators will follow their outcomes prospectively. Biologic samples (including blood, urine, vaginal swabs, placental tissue) will be collected at enrollment and at delivery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pregnancy Complications, Pregnancy Related, Weight Gain, Weight Change Trajectory, High Risk Pregnancy, Stress, Emotional

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized Controlled Trial
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
250 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Usual care
Arm Type
No Intervention
Arm Description
Women randomized to this group will receive no guidance regarding exercise / activity / sleep during pregnancy.
Arm Title
Activity Intervention
Arm Type
Experimental
Arm Description
Women randomized to this group will receive detailed information and reminders about physical activity and sleep in pregnancy. .
Intervention Type
Behavioral
Intervention Name(s)
Activity Intervention
Intervention Description
After 1 week of baseline activity is obtained, participants will be contacted with personalized activity goals that are 10% higher than their previous weeks' activity levels. They will also receive feedback regarding sleep if they are not averaging at least 6 hours per night or if they are waking more than twice per night. Participants will also receive weekly text reminders and encouraging feedback, and will receive additional counseling in person at regularly scheduled prenatal visits until delivery.
Primary Outcome Measure Information:
Title
Reduction in Perceived Maternal Stress
Description
Perceived stress score will be calculated using a validated 10-question stress scale; score = 14 indicates moderate stress
Time Frame
through delivery, an average of 7 months per participant
Title
Proportion of women with adverse perinatal outcomes
Description
The investigators will define adverse pregnancy outcomes as a composite of preterm birth <37 weeks, intrauterine growth restriction, preeclampsia, and placental abruption; outcomes will be compared between randomization groups.
Time Frame
outcome will be ascertained at delivery
Secondary Outcome Measure Information:
Title
Number of activity goals met by personalized activity level group
Description
Proportion of weekly activity goals that were successfully met by women randomized to personalized activity group
Time Frame
through delivery, an average of 7 months per participant
Title
Mean Daily steps
Description
Mean number of daily steps; amount will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant
Title
Median Daily steps
Description
median number of daily steps; amount will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant
Title
Mean 'Moderate' or greater physical activity
Description
Mean number of weekly minutes of 'moderate' or 'intense' physical activity as registered by the wrist-based activity monitor; amount will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant
Title
Median 'Moderate' or greater physical activity
Description
median number of weekly minutes of 'moderate' or 'intense' physical activity as registered by the wrist-based activity monitor; amount will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant
Title
Mean Nightly sleep minutes
Description
Mean number of sleep minutes per night; amount will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant
Title
Median Nightly sleep minutes
Description
median number of sleep minutes per night; amount will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant
Title
Median resting heart rate parameters
Description
The change in the median resting heart rate level and nadir of the resting heart rate (in beats per minute), between enrollment and delivery ; amount will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant
Title
Mean Resting heart rate parameters
Description
The change in the mean resting heart rate level and nadir of the resting heart rate (in beats per minute), between enrollment and delivery ; amount will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant
Title
Median Body composition change during study - total body water
Description
The change in median total body water measurements between enrollment and re-assessment at 8 and 16 weeks (as applicable, if still pregnant) after enrollment will be compared between randomization groups.
Time Frame
through reassessment of body composition at 16 weeks after randomization, an average of 4 months per participant.
Title
Mean Body composition change during study - total body water
Description
The change in mean total body water measurements between enrollment and re-assessment at 8 and 16 weeks (as applicable, if still pregnant) after enrollment will be compared between randomization groups.
Time Frame
through reassessment of body composition at 16 weeks after randomization, an average of 4 months per participant.
Title
Median Body composition change during study - percent body fat
Description
The change in median percent body fat measurements between enrollment and re-assessment at 8 and 16 weeks (as applicable, if still pregnant) after enrollment will be compared between randomization groups.
Time Frame
through reassessment of body composition at 16 weeks after randomization, an average of 4 months per participant.
Title
Mean Body composition change during study - percent body fat
Description
The change in mean percent body fat measurements between enrollment and re-assessment at 8 and 16 weeks (as applicable, if still pregnant) after enrollment will be compared between randomization groups.
Time Frame
through reassessment of body composition at 16 weeks after randomization, an average of 4 months per participant.
Title
Gestational weight gain
Description
The amount of weight gained by each participant during pregnancy, in pounds. outcomes will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant
Title
Gestational weight gain, per week after study enrollment
Description
The amount of weight gained per week by each participant, in pounds, between study enrollment and delivery. outcomes will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant
Title
Proportion of women with gestational diabetes mellitus
Description
The diagnosis of gestational diabetes mellitus during pregnancy, using standard criteria as set forth by American College of Obstetricians and Gynecologists. outcomes will be compared between randomization groups.
Time Frame
through delivery, an average of 7 months per participant.
Title
Proportion of women with hypertensive complications of pregnancy
Description
The diagnosis of gestational hypertension, preeclampsia, or eclampsia, using standard American College of Obstetricians and Gynecologists diagnostic criteria. outcomes will be compared between randomization groups.
Time Frame
through 6 weeks' postpartum, an average of 7 months per participant

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
51 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: At high risk for adverse pregnancy outcomes, due to either body mass index ≥ 30 kg/m^2, or a prior history of preeclampsia, intrauterine growth restriction or preterm birth prior to 37 weeks' gestation in a previous pregnancy and a perceived stress score of >/= 14 (10-question scale) Gestational age of 8.0 to 19.9 weeks' gestation using American College of Obstetricians and Gynecologists dating criteria (combination of ultrasound and menstrual dating, as available) Current singleton viable intrauterine pregnancy. Spontaneous reduction of twin to singleton gestation is allowable provided it occurred prior to 14 weeks' gestation. No structural abnormalities or aneuploidy Ability to communicate in and provide consent in English Maternal age 18 to 51 years of age Owns smartphone compatible with wrist-based activity tracker (over 200 devices supported) Exclusion Criteria: Women pregnant with multifetal gestations Women who have a medical condition where a modest increase in low-impact activity is contraindicated (at the discretion of the woman's treating physician) Planned delivery prior to 36 weeks' of gestation Unwilling to wear wrist-based activity tracker for at least 6 out of 7 days per week
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Tracy A Manuck, MD
Phone
919-966-1601
Email
tmanuck@med.unc.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tracy A Manuck, MD
Organizational Affiliation
University of North Carolina, Chapel Hill
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of North Carolina
City
Chapel Hill
State/Province
North Carolina
ZIP/Postal Code
27599
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Tracy Manuck, MD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Deidentified individual data that supports the results will be shared beginning 12 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with the University of North Carolina (UNC).
IPD Sharing Time Frame
12 to 36 months after initial publication
IPD Sharing Access Criteria
Access will be given provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with UNC.
Citations:
PubMed Identifier
15343232
Citation
Olson CM, Strawderman MS, Reed RG. Efficacy of an intervention to prevent excessive gestational weight gain. Am J Obstet Gynecol. 2004 Aug;191(2):530-6. doi: 10.1016/j.ajog.2004.01.027.
Results Reference
background
PubMed Identifier
22513947
Citation
Muktabhant B, Lumbiganon P, Ngamjarus C, Dowswell T. Interventions for preventing excessive weight gain during pregnancy. Cochrane Database Syst Rev. 2012 Apr 18;4(4):CD007145. doi: 10.1002/14651858.CD007145.pub2.
Results Reference
background
PubMed Identifier
26068707
Citation
Muktabhant B, Lawrie TA, Lumbiganon P, Laopaiboon M. Diet or exercise, or both, for preventing excessive weight gain in pregnancy. Cochrane Database Syst Rev. 2015 Jun 15;2015(6):CD007145. doi: 10.1002/14651858.CD007145.pub3.
Results Reference
background
PubMed Identifier
23836014
Citation
Wolf HT, Owe KM, Juhl M, Hegaard HK. Leisure time physical activity and the risk of pre-eclampsia: a systematic review. Matern Child Health J. 2014 May;18(4):899-910. doi: 10.1007/s10995-013-1316-8. Erratum In: Matern Child Health J. 2014 Oct;18(8):2020-3.
Results Reference
background
PubMed Identifier
12719446
Citation
Sorensen TK, Williams MA, Lee IM, Dashow EE, Thompson ML, Luthy DA. Recreational physical activity during pregnancy and risk of preeclampsia. Hypertension. 2003 Jun;41(6):1273-80. doi: 10.1161/01.HYP.0000072270.82815.91. Epub 2003 Apr 28.
Results Reference
background

Learn more about this trial

Sleep and Tracking Effects in Pregnancy Study

We'll reach out to this number within 24 hrs